Washington, DC 20006-5349
HELPLINE
Separately, chemotherapy and immunotherapy are both approved to treat mesothelioma, and individually they work equally well for those patients with the epithelioid type of disease.…
Watch this episode on YouTube. In this episode of MesoTV, we meet with Joseph Friedberg, MD, FACS, a thoracic surgeon at Temple University Hospital-Main Campus…
Mesothelioma community member, patient, and Meso Foundation’s board member, Jessica Blackford-Cleeton just concluded her participation in the review process for the Congressionally Directed Medical Research…
Last week, the Polaris Group announced positive results of its Phase 2/3 clinical trial evaluating the effectiveness of an arginine degrading enzyme agent called ADI-PEG 20.…
On this Mesothelioma Awareness Day, the mesothelioma community will once again work in their local communities to light the world blue! As part of this…
The Mesothelioma Applied Research Foundation is proud to announce the recipients of its most recent round of new mesothelioma research funding. Through a rigorous review…
On July 22 and 23rd, the mesothelioma community once again gathered at the Mesothelioma Applied Research Foundation’s International Symposium on Malignant Mesothelioma (also known more…
Today, the Mesothelioma Applied Research Foundation announced its 2022 mesothelioma award recipients for its Pioneer Award, the Klaus Brauch Above and Beyond Award, and the…
For over 18 years, the International Symposium on Malignant Mesothelioma has been the go-to place for mesothelioma patients and their families to find community and…
A new study just published in the journal Science challenged our collective hope that natural infection by Omicron would convey a degree of immunity that…
Get the latest information about mesothelioma, clinical trials, patient stories, community events, and much more!
